![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Cell Source's Megadose Drug Combination Receives Regulatory Approval in Italy to Commence Human Clinical Trials Independent, 3rd Party Researchers at Italian University to Conduct Study PR...
Cell Source to Present at the FireRock Conference and the Life Sciences Summit in New York City on October 28th and 29th, 2014 PR Newswire TEL AVIV, Israel, Oct. 8, 2014 TEL AVIV, Israel, Oct. 8...
Cell Source to Present at Rodman & Renshaw Global Investment Conference in New York City on September 10, 2014 PR Newswire TEL AVIV, Israel, Sept. 3, 2014 TEL AVIV, Israel, Sept. 3, 2014...
Cell Source Inc. Announces Acquisition and $3.6 Million Private Placement to Advance Novel Cancer Therapies PR Newswire TEL AVIV, Israel and NEW YORK, July 1, 2014 TEL AVIV, Israel and NEW...
Period † | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions